| Name | Fexapotide |
|---|
| Description | Fexapotide (NX-1207 free acid) induces apoptosis selectively, reducing prostate volume at a cellular level. Fexapotide can be used in lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) research[1][2][3]. |
|---|---|
| Related Catalog |
| Molecular Formula | C90H163N27O25S |
|---|---|
| Molecular Weight | 2055.49 |